FOXM1 and nasopharyngeal carcinoma: FOXM1 that is upregulated in NPC has been identified as potential therapeutic and prognostic marker of NPC [39, 40], which participates in the malignant progress of NPC, including cell cycle progression, proliferation, migration, invasion, apoptosis, angiogenesis, stemness, glycolysis, metastasis, and resistance [30, 41–50].